Innovita Research Foundation

I.R.F. / Survey / Chapter 2

Download printable version

Aging, The Molecular Concepts

Chapter 2 References

  1. Wallace DC. Mitochondrial DNA mutations and bioenergetic defects in aging and degenerative diseases. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, eds. The molecular and genetic basis of neurological disease. Boston: Butterworth and Heinemann, 1997.
  2. Bandy B, Davison AJ. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Rad Biol Med 1990: 8: 523-39.
  3. Boveris A, Turrens JR Production ofsuperoxide anion by the NADH-dehydrogenase ofmamalian mitochondria. In: Bannister JV, Hill HAO, eds. Chemical and biochemical aspects of superoxide and superoxide dismutase. Developments in biochemistry. New York: Elsevier-North Holland, 1980: 84-91.
  4. Ksenzenko M, Konstantinov AA, Khomutov GB, Tikhonov AN, Ruuge EK. Effect of electron transfer inhibitors on superoxide generation in the cytochrome bcl site of the mitochondrial respiratory chain. FEBS Lett 1983: 155: 19-24.
  5. Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 1985: 237: 408-14.
  6. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 1980: 191: 421-7.
  7. Goldhaber JI, Weiss JN. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 1992:20: 118-27.
  8. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol 1984: 105: 429-35.
  9. Boveris A, Oshino N, Chance B. The cellular production of hydrogen peroxide. Biochem J 1972: 128: 617-30.
  10. Cadenas E, Boveris A. Enhancement of hydrogen peroxide formation by protophores and ionophores in antimycin-supplemented mitochondria. Biochem J 1980: 188: 31-7.
  11. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979: 59: 527-605.
  12. Ohkoshi N, Mizusawa H, Shiraiwa N, Shoji S, Harada K, Yoshizawa K. Superoxide dismutases of muscle in mitochondrial encephalomyopathies. Muscle and Nerve 1995: 18: 1265-71.
  13. Pitkanen S, Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction ofsuperoxide dismutase. J din Invest 1996: 98: 345-51.
  14. Rotig A, de Lonlay P, Chretien D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nature Genet 1997: 17: 215-7.
  15. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 1995: 1535-609.
  16. Wallace DC. Diseases of the mitochondrial DNA. Ann Rev Biochem 1992: 61: 1175-212.
  17. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992: 256: 628-32.
  18. Wallace DC, Brown MD, Lott MT. Mitochondrial Genetics. In: Rimoin DL, Connor JM, Pyeritz RE, Emery AEH, eds. Emery and Rimoin's principles and practice of medical genetics. London: Churchill Livingstone, 1996: 277-332.
  19. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988: 242: 1427-30.
  20. Howell N, Bindoff LA, McCullough DA, et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991: 49: 939-50.
  21. Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus ML. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 1991: 48: 1147-53.
  22. Johns DR, Neufeld MJ, Park RD. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 1992: 187: 1551-7.
  23. Mackey D, Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet 1992: 51: 1218-28.
  24. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at np 14459 of the ND6 gene associated with maternally inherited Leber's hereditary optic neuropathy and dystonia. Proc Nati AcadSci USA 1994: 91: 6206-10.
  25. Jun AS, Trounce IA, Brown MD, Shoffner JM, Kim YL, Wallace DC. Marked complex I deficiency in patients harboring the np 14459 ND6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy and dystonia. Am J Hum Genet 1994: 55 (Suppl.): A225 (Abstr. 1311).
  26. Novotny EJ, Singh G, Wallace DC, Dorfman LJ, Louis A, Sogg RL, Steinman L. Leber's disease and dystonia: a mitochondrial disease. Neurology 1986: 36: 1053-60.
  27. Shoffner JM, Brown MD, Stugard C, et al. Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation in a complex I subunit. Ann Neurol 1995: 38: 163-9.
  28. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990: 46: 428-33.
  29. Ortiz RG, Newman NJ, Shoffner JM, Kaufman AE, Koontz DA, Wallace DC. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch Ophthalmol 1993: 111: 1525-30.
  30. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992: 50: 852-8.
  31. Fischel-Ghodsian N, Prezant TR, Bu X, Oztas S. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am J Otolaryngol 1993: 14: 399-403.
  32. Hutchin T, Haworth I, Higashi K, et al. A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucl Acids Res 1993: 21: 4174-9.
  33. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA^ mutation. Cell 1990: 61: 931-7.
  34. Wallace DC, Zheng X, Lott MT, et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988: 55: 601-10.
  35. Goto Y, Nonaka I, Horai S. A mutation in the tRNA gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990: 348: 651-3.
  36. Kobayashi Y, Momoi MY, Tominaga K, et al. A point mutation in the mitochondrial tRNA(uur) gene MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 1990: 173: 816-22.
  37. Shoffner JM, Bialer MG, Pavlakis SG, et al. Mitochondrial encephalomyopathy associated with a single nucleotide pair deletion in the mitochondrial tRNA gene. Neurology 1995: 45: 286-92.
  38. Hutchin T, Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Nat Acad Sci USA 1995: 92: 6892-5.
  39. Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993: 17: 171-84.
  40. Wallace DC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Nati Acad Sci USA 1994: 91: 8739-46.
  41. Ballinger SW, Shoffner JM, Gebhart S, Koontz DA, Wallace DC. Mitochondrial diabetes revisited. Nature Genet 1994: 7: 458-9.
  42. Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet 1992: 1: 11-5.
  43. Poulton J, Morten KJ, Marchington D, et al. Duplications of mitochondrial DNA in Kearns-Sayre syndrome. Muscle and Nerve 1995: 3: S154-8.
  44. Rowland LP. Molecular genetics, pseudogenetics, and clinical neurology. Neurology 1983: 33: 1179-95.
  45. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988: 331: 717-9.
  46. Schon EA, Rizzuto R, Moraes CT, Nakase H, Zeviani M, DiMauro S. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 1989: 244: 346-9.
  47. Shoffner JM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Nati Acad Sci USA 1989: 86: 7952-6.
  48. Mita S, Schmidt B, Schon EA, DiMauro S, Bonilla E. Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc Nat Acad Sci USA 1989: 86: 9509-13.
  49. Shoubridge EA, Karpati G, Hastings KEM. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 1990: 62: 43-9.
  50. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic function. J Pediatr 1979: 95: 976.
  51. Rotig A, Bourgeron T, Chretien D, Rustin P, Munnich A. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 1995: 4: 1327-30.
  52. McShane MA, Hammans M, Sweeney I, et al. Pearson Syndrome and mitochondrial encephalomyopathy in patient with a deletion ofmtDNA. Am J Hum Genet 1991: 48: 39-42.
  53. Benecke R, Strumper P, Weiss H. Electron transfer complex I defect in idiopathic dystonia. Ann Neurol 1992: 32: 683-6.
  54. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983: 219: 979-80.
  55. Schapira AHV. Mitochondria dysfunction in neurodegenerative disorders and aging. In: Schapira AHV, DiMauro S, eds. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann Ltd., 1994: 227-44.
  56. Singer TP, Castagnoli N Jr, Ramsay RR, Trevor AJ. Biochemical events in the development of parkinsonism induced by l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. J Neurochem 1987: 49: 1-8.
  57. Schapira AH, Cooper JM, Dexter D, dark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990: 54: 823-7.
  58. Schapira AH, Cooper JM, Dexter D, Jenner P, dark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989: I: 1269.
  59. Parker WD, Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989: 26: 719-23.
  60. Boffoli D, Scacco SC, Vergari R, Solarino G, Santacroce G, Papa S. Decline with age of'the respiratory chain activity in human skeletal muscle. Biochim Biophys Acta 1994: 1226: 73-82.
  61. Cooper JM, Mann VM, Schapira AHV. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J Neurol Sci 1992: 113: 91-8.
  62. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1989: I: 637-9.
  63. Yen TC, Chen YS, King KL, Yeh SH, Wei YH. Liver mitochondrial respiratory functions decline with age. Biochem Biophys Res Commun 1989: 165: 944-1003.
  64. Bowling AC, Mutisya EM, Walker LC, Price DL, Cork LC, Beal MR Age-dependent impairment of mitochondrial function in primate brain. J Neurochem 1993: 60: 1964-7.
  65. Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle (published erratum appears in Nucl Acids Res 1995 Dec 11; 23: 4938). Nucl Acids Res 1995: 23: 4122-6.
  66. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992: 275: 169-80.
  67. Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction. JAMA 1991: 266: 1812-6.
  68. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet 1992: 2: 324-9.
  69. Lezza AM, Boffoli D, Scacco S, Cantatore P, Gadaleta MN. Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles. Biochem Biophys Res Commun 1994: 205: 772-9.
  70. Simonetti S, Chen X, DiMauro S, Schon EA. Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim Biophys Acta 1992: 1180: 113-22.
  71. Hayakawa M, Sugiyama S, Hattori K, Takasawa M, Ozawa T. Ageassociated damage in mitochondrial DNA in human hearts. Mol Cell Biochem 1993: 119: 95-103.
  72. Soong NW, Hinton DR, Cortopassi G, Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genet 1992: 2: 318-23.
  73. Das DK, George A, Liu XK, Rao PS. Detection of hydroxyl radical in the mitochondria of ischemic-reperfused myocardium by trapping with salicylate. Biochem Biophys Res Commun 1989: 165: 1004-9.
  74. Corral-Debrinski M, Horton T, Lott MT, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994: 23: 471-6.
  75. Horton TM, Graham BH, Corral-Debrinski M, et al. Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's Disease patients. Neurology 1995: 45: 1879-83.
  76. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Nati Acad Sci USA 1993: 90: 7915-22.
  77. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Nati Acad Sci USA 1988: 85: 6465-7.
  78. Mecocci P, MacGarvey U, Kaufman AE, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993: 34: 609-16.
  79. Melov S, Hinerfeld D, Esposito L, Wallace DC. Multi-organ characterization of mitochondrial genomic rearrangements in ad libitum and caloric restricted mice show striking somatic mitochondrial DNA rearrangements with age. Nucl Acids Res 1997: 25: 974-82.
  80. Masoro EJ. Dietary restriction and aging. J Am Geriatr Soc 1993: 41: 994-9.
  81. Masoro EJ, McCarter RJ, Katz MS, McMahan CA. Dietary restriction alters characteristics of glucose fuel use (published erratum appears in J Gerontol 1993 Mar; 48: B73). J Gerontol 1992: 47: B202-8.
  82. Sohal RS, Ku HH, Agarwal S, Forster MJ, Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Ageing Devel 1994: 74: 121-33.
  83. Graham B, Waymire K, Cottrell B, Trounce IA, MacGregor GR, Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/skeletal muscle isoform of the adenine nucleotide translocator. Nature Genet 1997: 16: 226-34.
  84. Ellison JW, Li X, Francke U, Shapiro LJ. Rapid evolution of human pseudoautosomal genes and their mouse homologs. Mammal Genome 1996: 7: 25-30.
  85. Gardner PR, Nguyen DD, White CW Superoxide scavenging by Mn(II/III) tetrakis (l-methyl-4-pyridyl) porphyrin in mammalian cells. Arch Biochem Biophys 1996: 325: 20-8.
  86. Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ. Unpublished data. 1995.
  87. Reaume AG, Elliott JL, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 1996: 13: 43-7.
  88. Carlsson LM, Jonsson J, Ediund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Nat Acad Sci USA 1995: 92: 6264-8.
  89. Melov S, Schneider JA, Day BJ, et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nature Genet 1998: 18: 159-63.
< Previous | Contents | Next >